Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form
|
|
- Garey Ford
- 5 years ago
- Views:
Transcription
1 Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form November 2017 Dag Are Steenhoff Hov, PubGene AS 1
2 PubGene, founded 2001 ArrayIt H25K microarray Integration of structured and unstructured information Interpretation of biomedical analysis data General information Specialized information analysis Scientific Literature Coremine Networks COREMINE Oncology COREMINE Medical COREMINE Platform 2
3 Clinical NLP in PubGene - examples Clinical trials in Coremine Oncology PubGene in Ahus Optique Courtesy of DNV-GL (Tore Hartvigsen) 3
4 Coremine Oncology AIM: To enable oncologists to make better treatment decisions HOW: Combine data from relevant sources to aid interpretation of oncogenomics data from NGS and other platforms Input: Somatic mutations, copy number changes, gene expression, or similar quantity Output: Gene/biomarker annotations, related drugs and drug sensitivity, pathways, clinical trials, etc. 4
5 Coremine Oncology Our Scope We focus on: Analysis of called events ; assumed that normalization and data quality considerations have been taken care of Collecting and integrating information for interpretation Linking to potentially relevant treatments Linking to clinical trials related to the input data 5
6 Coremine Oncology Currently three types of input data: (Somatic) mutations Copy number changes gene expression Analysis/Interpretation module to display information (annotations) about Mutation Gene/Protein Protein Domains Summary module to show patient level information with respect to: Statistics on mutations Related drugs for targets with change (in progress: also biomarker and sensitivity info) Pathways for targets with change Relevant clinical trials for aberrations 6
7 Example Somatic mutations input data Input for Coremine Oncology, case from lung cancer Chromosome number Position Reference nucleotide Alternate nucleotide 7
8 View of imported data file
9 Mutation annotation 1 patient - 1 missense mutation
10 10
11 Clinical Trials for Cetuximab 11
12 Clinical Trials for biomarkers AIM: To map biomarkers from patient data to relevant clinical trials METHOD: Identify how biomarkers are mentioned (referred to) in clinical trials Download and index data from clinicaltrials.gov Develop dictionaries of biomarkers and methods for detecting these in trial descriptions Focus on eligibility CHALLENGES Text mining is difficult! Biomarkers are described, or referred to in many ways Ultimately, we want to identify biomarkers related to eligibility, but this is not straightforward Complicated logic in inclusion/exclusion criteria, e.g., negation Also need to check title, description, and condition for biomarkers 12
13 Clinical Trials text data mining Compiled several lists of biomarkers of different types: Single-Nucleotide mutations (Cosmic) Polymorphisms Fusion genes Gene regulation (Exp-up/down) Copy number changes Several strategies for finding these in text: Detect explicit mentions Detect patterns based on gene name and marker type, e.g., GENE amplification GENE activating mutation Curated list of cancer types matched with conditions Statistics for patterns Expression: 135 CNV: 32 Other (positive/negative): 20/10 Mutation: 37 Fusion/rearrangement/translocation: 10 Indexing statistics 5350 trials with at least one biomarker 855 different biomarkers with hits Top markers: BCR/ABL1 (907), ERBB2 positive (725), ERBB2 negative (603), ESR1 positive (467), ERBB2 exp-up (403) 13
14 Clinical Trials for example case NSCLC and Erlotinib 14
15 Clinical Trials for copy number data (CNV) 15
16 Trials matching patient biomarkers and disease Cancer type, e.g., NSCLC Filter Manual curation Domain knowledge Clinical Trials GUI or command line CNA SNP EXP INDEL SNA FUSION 16
17 Clinical Trials for combined data NSCLC BRAF G469A BRAF D594G BRAF V600E EGFR T790M KIF5B/RET CD74/ROS1 KIF5B/ALK BCR/ABL1 17
18 Details from Clinical Trial information NCT
19 Clinical Trials matching to patient data Various levels of stringency for matching trial to patient Perfect match Other alteration (incl. same effect) Same gene (other biomarker) Related gene S = weighted sum of scores Biomarker specific scoring models due to different prioritization of relevance of other alterations AIM: To better map/identify other alterations with same/similar effect, e.g., amplification/up-regulation with activating mutation Example: Patient ERBB2 Exp up Trial: 1. Perfect match: ERBB2 Exp up 2. Same effect: ERBB2 CNV gain 3. Similar effect: ERBB2 Positive 4. Other alteration: ERBB2 mutation 5. Likely opposite effect: ERBB2 Neg. 6. Opposite effect: ERBB2 Exp down or, ERBB2 CNV loss 7. Gene Only: ERBB2 8. Related Gene: EGFR 19
20 Clinical NLP in PubGene - examples PubGene in Ahus Optique Courtesy of DNV-GL (Tore Hartvigsen) 20
21 Akershus University Hospital (Ahus) Optique project. Increase patient security by providing easier access to existing information Courtesy of DNV-GL (Tore Hartvigsen) Human touch and empathy with professional skill
22 The Surgery Planning Form is completed in 3 Stages Surgery Planning Form ( The Green Form ) Stage 1: Examination Stage 2: Preparations DIPS Ahus Structured data Text Metavision Ahus Metavision O Metavision I Metavision DKS Stage 3: Check/ QA Additional systems System System To complete the form, data must be collected from a number of systems! This is today done manually. Courtesy of DNV-GL (Tore Hartvigsen) 22
23 Leave the data in the source systems! Expert users «Ordinary» users Researchers/ Analysts A semantic IT solution and ontology for clinical use in Health Care Data warehousing is an option Ahus research Databases. Metavision O Metavision I Metavision DKS Ahus production databases DIPS DIPS (EPJ) (EPJ) (EPJ) Metav DIPS Courtesy of DNV-GL (Tore Hartvigsen) 23
24 We want to «lift» the data out of the silos! Expert users «Ordinary» users A semantic IT solution and ontology for clinical use in Health Care Structured data Unstructured data (text) Solutions provided by the Optique project Text mining Courtesy of DNV-GL (Tore Hartvigsen) 24
25 PubGene in Ahus Optique, information extraction Unstructured information Height 1,83 m Fields ASA BMI Height Weight Puls Blood pressure Temperature Diagnose codes Treatment codes Structured information name=height, type=int, unit=cm, value=183 25
26 PubGene i Ahus Optique, allergy information 26
27 PubGene i Ahus Optique, status on smoking Sentence Røyker. Røyker om dagen. Ifølge datter erhan også storrøyker, 40/ dag siste 50 år. Røykeplaster? Tidligere storrøyker. Ikke røyker og drikker ikke alkohol, tidligere, måteholdent alkoholbruk. Eks-røyker, lite alkohol. Status Yes Yes Yes Uncertain Stopped No Stopped Text analysis Separate text in sentences, detection of sentences containing røyke, røyki, røykt Classification of sentences based on recognition of keywords and word or sentence patterns NB: Based on a small database 27
28 Ahus Optique Screenshots Courtesy of DNV-GL (Tore Hartvigsen) 28
29 Courtesy of DNV-GL (Tore Hartvigsen)
30 Page for surgery planning form Courtesy of DNV-GL (Tore Hartvigsen)
31 Courtesy of DNV-GL (Tore Hartvigsen)
32 Courtesy of DNV-GL (Tore Hartvigsen) BMI
33 Courtesy of DNV-GL (Tore Hartvigsen)
34 Courtesy of DNV-GL (Tore Hartvigsen)
35 Courtesy of DNV-GL (Tore Hartvigsen)
36 Courtesy of DNV-GL (Tore Hartvigsen)
37 Allergy Courtesy of DNV-GL (Tore Hartvigsen)
38
39 Smoking Courtesy of DNV-GL (Tore Hartvigsen)
40 Courtesy of DNV-GL (Tore Hartvigsen)
41 Courtesy of DNV-GL (Tore Hartvigsen) Surgery planning form
42 Further development, text processing/analysis A large set of options and potential Far more effective collection of more relevant information, e.g., by filling surgery forms ( The green form ) Improved quality through automatic detection of errors in documents and control of consistency with structured data Further steps for Ahus Optique Simple: Extraction of more static fields, like lab results Information about medication Information on heart function, lung function Exploit document structure and information on document types 42
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationKnowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains
Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Dr. Sascha Losko, Dr. Karsten Wenger, Dr. Wenzel Kalus, Dr. Andrea Ramge, Dr. Jens Wiehler,
More informationSupplementary Figure 1
Supplementary Figure 1 An example of the gene-term-disease network automatically generated by Phenolyzer web server for 'autism'. The largest word represents the user s input term, Autism. The pink round
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationTransform genomic data into real-life results
CLINICAL SUMMARY Transform genomic data into real-life results Biomarker testing and targeted therapies can drive improved outcomes in clinical practice New FDA-Approved Broad Companion Diagnostic for
More informationFrequency(%) KRAS G12 KRAS G13 KRAS A146 KRAS Q61 KRAS K117N PIK3CA H1047 PIK3CA E545 PIK3CA E542K PIK3CA Q546. EGFR exon19 NFS-indel EGFR L858R
Frequency(%) 1 a b ALK FS-indel ALK R1Q HRAS Q61R HRAS G13R IDH R17K IDH R14Q MET exon14 SS-indel KIT D8Y KIT L76P KIT exon11 NFS-indel SMAD4 R361 IDH1 R13 CTNNB1 S37 CTNNB1 S4 AKT1 E17K ERBB D769H ERBB
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28
More informationAVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB
Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation
More informationIntegrated Analysis of Copy Number and Gene Expression
Integrated Analysis of Copy Number and Gene Expression Nexus Copy Number provides user-friendly interface and functionalities to integrate copy number analysis with gene expression results for the purpose
More informationBuilding Cognitive Computing for Healthcare
Building Cognitive Computing for Healthcare Boston University Digital Health Initiative Round Table February 27 th 2017 Patrick McNeillie M.D. Clinical Lead and Senior Architect on Watson for Genomics
More informationKEY FINDINGS 1. Potential Clinical Benefit in Non-Small Cell Lung Cancer with Gefitinib, Erlotinib, Afatinib due to EGFR E746_A750del. 2. Potential Cl
PATIENT INFO SAMPLE REFERING PHYSICIAN COPY TO (if different from ordering) Name: John Smith Date Collected: 10/23/2016 Name: Oncologist, M.D. Name: Pathologist, M.D. DOB: 04/22/1937 Date Received: 10/24/2016
More informationHow can Natural Language Processing help MedDRA coding? April Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics
How can Natural Language Processing help MedDRA coding? April 16 2018 Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics Summary About NLP and NLP in life sciences Uses of NLP with MedDRA
More informationModule 3: Pathway and Drug Development
Module 3: Pathway and Drug Development Table of Contents 1.1 Getting Started... 6 1.2 Identifying a Dasatinib sensitive cancer signature... 7 1.2.1 Identifying and validating a Dasatinib Signature... 7
More informationOncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies
OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...
More informationNCCN Non-Small Cell Lung Cancer V Meeting June 15, 2018
Guideline Page and Request Illumina Inc. requesting to replace Testing should be conducted as part of broad molecular profiling with Consider NGS-based assays that include EGFR, ALK, ROS1, and BRAF as
More informationAnalysis with SureCall 2.1
Analysis with SureCall 2.1 Danielle Fletcher Field Application Scientist July 2014 1 Stages of NGS Analysis Primary analysis, base calling Control Software FASTQ file reads + quality 2 Stages of NGS Analysis
More informationInnovative Risk and Quality Solutions for Value-Based Care. Company Overview
Innovative Risk and Quality Solutions for Value-Based Care Company Overview Meet Talix Talix provides risk and quality solutions to help providers, payers and accountable care organizations address the
More informationCancer Informatics Lecture
Cancer Informatics Lecture Mayo-UIUC Computational Genomics Course June 22, 2018 Krishna Rani Kalari Ph.D. Associate Professor 2017 MFMER 3702274-1 Outline The Cancer Genome Atlas (TCGA) Genomic Data Commons
More informationDeSigN: connecting gene expression with therapeutics for drug repurposing and development. Bernard lee GIW 2016, Shanghai 8 October 2016
DeSigN: connecting gene expression with therapeutics for drug repurposing and development Bernard lee GIW 2016, Shanghai 8 October 2016 1 Motivation Average cost: USD 1.8 to 2.6 billion ~2% Attrition rate
More informationStandardize and Optimize. Trials and Drug Development
Informatics Infrastructure to Standardize and Optimize Quantitative Imaging in Clinical Trials and Drug Development Daniel L. Rubin, MD, MS Assistant Professor of Radiology Member, Stanford Cancer Center
More informationTumor mutational burden and its transition towards the clinic
Tumor mutational burden and its transition towards the clinic G C C A T C A C Wolfram Jochum Institute of Pathology Kantonsspital St.Gallen CH-9007 St.Gallen wolfram.jochum@kssg.ch 30th European Congress
More informationNext generation diagnostics Bringing high-throughput sequencing into clinical application
Next generation diagnostics Bringing high-throughput sequencing into clinical application Leonardo A. Meza-Zepeda, PhD Translational Genomics Group Institute for Cancer Research Leonardo.Meza-Zepeda@rr-research.no
More informationNGS ONCOPANELS: FDA S PERSPECTIVE
NGS ONCOPANELS: FDA S PERSPECTIVE CBA Workshop: Biomarker and Application in Drug Development August 11, 2018 Rockville, MD You Li, Ph.D. Division of Molecular Genetics and Pathology Food and Drug Administration
More information6/12/2018. Disclosures. Clinical Genomics The CLIA Lab Perspective. Outline. COH HopeSeq Heme Panels
Clinical Genomics The CLIA Lab Perspective Disclosures Raju K. Pillai, M.D. Hematopathologist / Molecular Pathologist Director, Pathology Bioinformatics City of Hope National Medical Center, Duarte, CA
More informationNGS IN ONCOLOGY: FDA S PERSPECTIVE
NGS IN ONCOLOGY: FDA S PERSPECTIVE ASQ Biomed/Biotech SIG Event April 26, 2018 Gaithersburg, MD You Li, Ph.D. Division of Molecular Genetics and Pathology Food and Drug Administration (FDA) Center for
More information38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16
38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16 PGAR: ASD Candidate Gene Prioritization System Using Expression Patterns Steven Cogill and Liangjiang Wang Department of Genetics and
More informationData mining with Ensembl Biomart. Stéphanie Le Gras
Data mining with Ensembl Biomart Stéphanie Le Gras (slegras@igbmc.fr) Guidelines Genome data Genome browsers Getting access to genomic data: Ensembl/BioMart 2 Genome Sequencing Example: Human genome 2000:
More informationSALSA MLPA probemix P315-B1 EGFR
SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional
More informationMY LUNG CANCER CARE PLAN
MY LUNG CANCER CARE PLAN MANAGE DIAGNOSIS TRACK TREATMENTS & APPOINTMENTS MONITOR SYMPTOMS FREE TO BREATHE SUPPORT LINE (844) 835-4325 A FREE resource for lung cancer patients & caregivers We are Free
More informationClinical Biomarker in Kidney Cancer. Maria Nirvana Formiga, M.D., Ph.D.
Clinical Biomarker in Kidney Cancer Maria Nirvana Formiga, M.D., Ph.D. Disclosures I am on the Speaker s Bureau with Pfizer and Bayer Clinical trials of BMS and Pfizer Kidney Cancer 70% new cases in developed
More informationCorporate Medical Policy
Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer
More informationReporting TP53 gene analysis results in CLL
Reporting TP53 gene analysis results in CLL Mutations in TP53 - From discovery to clinical practice in CLL Discovery Validation Clinical practice Variant diversity *Leroy at al, Cancer Research Review
More informationThe Cancer Genome Atlas & International Cancer Genome Consortium
The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1
More informationThe Role of Next Generation Sequencing in Solid Tumor Mutation Testing
The Role of Next Generation Sequencing in Solid Tumor Mutation Testing Allie H. Grossmann MD PhD Department of Pathology, University of Utah Division of Anatomic Pathology & Oncology, ARUP Laboratories
More informationBreast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS
Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS dr sc. Ana Krivokuća Laboratory for molecular genetics Institute for Oncology and
More informationUniversity of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13
University of Pittsburgh Cancer Institute UPMC CancerCenter Uma Chandran, MSIS, PhD chandran@pitt.edu 412-648-9326 2/21/13 University of Pittsburgh Cancer Institute Founded in 1985 Director Nancy Davidson,
More information5 th July 2016 ACGS Dr Michelle Wood Laboratory Genetics, Cardiff
5 th July 2016 ACGS Dr Michelle Wood Laboratory Genetics, Cardiff National molecular screening of patients with lung cancer for a national trial of multiple novel agents. 2000 NSCLC patients/year (late
More informationIdentifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?
Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer
More informationSupplementary Online Content
Supplementary Online Content Kris MG, Johnson BE, Berry LD, et al. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs. JAMA. doi:10.1001/jama.2014.3741 etable 1. Trials
More informationRefining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis
5/17/13 Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis Johannes Kratz, MD Post-doctoral Fellow, Thoracic Oncology Laboratory
More informationIntroduction to the Partners Biobank Portal. December 2016
Introduction to the Partners Biobank Portal December 2016 Agenda About the Partners Biobank About the Biobank Portal Data Types in the Biobank Sample types DNA. Plasma and Serum Consent Genomic Data Health
More informationLUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia
LUNG CANCER pathology & molecular biology Izidor Kern University Clinic Golnik, Slovenia 1 Pathology and epidemiology Small biopsy & cytology SCLC 14% NSCC NOS 4% 70% 60% 50% 63% 62% 61% 62% 59% 54% 51%
More informationClinical Grade Genomic Profiling: The Time Has Come
Clinical Grade Genomic Profiling: The Time Has Come Gary Palmer, MD, JD, MBA, MPH Senior Vice President, Medical Affairs Foundation Medicine, Inc. Oct. 22, 2013 1 Why We Are Here A Shared Vision At Foundation
More informationContents. 1.5 GOPredict is robust to changes in study sets... 5
Supplementary documentation for Data integration to prioritize drugs using genomics and curated data Riku Louhimo, Marko Laakso, Denis Belitskin, Juha Klefström, Rainer Lehtonen and Sampsa Hautaniemi Faculty
More informationPersonalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients
Personalised cancer care Information for Medical Specialists A new way to unlock treatment options for your patients Contents Optimised for clinical benefit 4 Development history 4 Full FIND IT panel vs
More informationHands-On Ten The BRCA1 Gene and Protein
Hands-On Ten The BRCA1 Gene and Protein Objective: To review transcription, translation, reading frames, mutations, and reading files from GenBank, and to review some of the bioinformatics tools, such
More informationSAGE. Nick Beard Vice President, IDX Systems Corp.
SAGE Nick Beard Vice President, IDX Systems Corp. Sharable Active Guideline Environment An R&D consortium to develop the technology infrastructure to enable computable clinical guidelines, that will be
More informationIPA Advanced Training Course
IPA Advanced Training Course October 2013 Academia sinica Gene (Kuan Wen Chen) IPA Certified Analyst Agenda I. Data Upload and How to Run a Core Analysis II. Functional Interpretation in IPA Hands-on Exercises
More informationCOSMIC - Catalogue of Somatic Mutations in Cancer
COSMIC - Catalogue of Somatic Mutations in Cancer http://cancer.sanger.ac.uk/cosmic https://academic.oup.com/nar/articl e-lookup/doi/10.1093/nar/gkw1121 Data In Large-scale systematic screens Detailed
More informationInfrastructure for Clinical Data Exchange
Infrastructure for Clinical Data Exchange Amy Abernethy, MD, PhD FEBRUARY 29 2016 Instrument Data Highly Structured Administrative Data Highly Structured Clinical Research Data Intentionally Structured
More informationMolecular Testing in Lung Cancer
Molecular Testing in Lung Cancer Pimpin Incharoen, M.D. Assistant Professor, Thoracic Pathology Department of Pathology, Ramathibodi Hospital Genetic alterations in lung cancer Source: Khono et al, Trans
More informationShashikant Kulkarni, M.S (Medicine)., Ph.D., FACMG Associate Professor of Pathology & Immunology Associate Professor of Pediatrics and Genetics
Shashikant Kulkarni, M.S (Medicine)., Ph.D., FACMG Associate Professor of Pathology & Immunology Associate Professor of Pediatrics and Genetics Director of Cytogenomics and Molecular Pathology Evidence-based
More information7/6/2015. Cancer Related Deaths: United States. Management of NSCLC TODAY. Emerging mutations as predictive biomarkers in lung cancer: Overview
Emerging mutations as predictive biomarkers in lung cancer: Overview Kirtee Raparia, MD Assistant Professor of Pathology Cancer Related Deaths: United States Men Lung and bronchus 28% Prostate 10% Colon
More informationSteps to Creating a New Workout Program
Steps to Creating a New Workout Program Step 1: Log into lab website: https://fitnessandhealthpromotion.ca/ a. If you have never logged in, use your FOL username without the @fanshaweonline.ca portion
More informationFrom somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards
Perera-Bel et al. Genome Medicine (2018) 10:18 https://doi.org/10.1186/s13073-018-0529-2 RESEARCH From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular
More informationComprehensive Genomic Profiling, in record time. Accurate. Clinically Proven. Fast.
Comprehensive Genomic Profiling, in record time Accurate. ly Proven. Fast. PCDx advantages Comprehensive genomic profiling, in record time PCDx Comprehensive Genomic Profiling (CGP) provides precise information
More informationVariant interpretation exercise. ACGS Somatic Variant Interpretation Workshop Joanne Mason 21/09/18
Variant interpretation exercise ACGS Somatic Variant Interpretation Workshop Joanne Mason 21/09/18 Format of exercise Compile a list of tricky variants across solid cancer and haematological malignancy.
More informationStatistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets
Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets Bibhas Chakraborty, PhD Centre for Quantitative Medicine, Duke-NUS March 29, 2015 Personalized or Precision Medicine
More informationIntroduction to LOH and Allele Specific Copy Number User Forum
Introduction to LOH and Allele Specific Copy Number User Forum Jonathan Gerstenhaber Introduction to LOH and ASCN User Forum Contents 1. Loss of heterozygosity Analysis procedure Types of baselines 2.
More informationI. Setup. - Note that: autohgpec_v1.0 can work on Windows, Ubuntu and Mac OS.
autohgpec: Automated prediction of novel disease-gene and diseasedisease associations and evidence collection based on a random walk on heterogeneous network Duc-Hau Le 1,*, Trang T.H. Tran 1 1 School
More informationPrecision Medicine Knowledgebase (PMKB)
Precision Medicine Knowledgebase (PMKB) https://pmkb.weill.cornell.edu/ https://academic.oup.com/jamia/article/24/ 3/513/2418181/The-cancer-precisionmedicine-knowledge-base-for Click on this to expand/collapse
More informationDavid Tamborero, PhD
David Tamborero, PhD Lopez-Bigas' lab Study of Tumor Genomes Study of Tumor Genomes Study sequencing data of tumors to understand the biological mechanisms shaping the mutational processes observed at
More informationCharacterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
More informationUpdated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors
Q: How is the strength of recommendation determined in the new molecular testing guideline? A: The strength of recommendation is determined by the strength of the available data (evidence). Strong Recommendation:
More informationJournal: Nature Methods
Journal: Nature Methods Article Title: Network-based stratification of tumor mutations Corresponding Author: Trey Ideker Supplementary Item Supplementary Figure 1 Supplementary Figure 2 Supplementary Figure
More informationData Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis
February, 13th 2018 Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies:
More informationCancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer
Cancer Gene Panels Dr. Andreas Scherer Dr. Andreas Scherer President and CEO Golden Helix, Inc. scherer@goldenhelix.com Twitter: andreasscherer About Golden Helix - Founded in 1998 - Main outside investor:
More informationComprehensive genomic profiling for various solid tumors
Content Highlight Test Specification Test Content Performance Validation Test Report I II III IV V The NovoPM TM comprehensive cancer genomic profiling test Comprehensive genomic profiling for various
More informationOncofocus. Patient Test Report
Oncofocus Patient Test Report Lead Clinical Scientist: Keeda Snelson Senior BMS: Tiffany Haddow Date: 08 Feb 2017 1 of 6 Comment: The DNA and RNA extracted from this sample were of optimal quantity. The
More informationA Simple Pipeline Application for Identifying and Negating SNOMED CT in Free Text
A Simple Pipeline Application for Identifying and Negating SNOMED CT in Free Text Anthony Nguyen 1, Michael Lawley 1, David Hansen 1, Shoni Colquist 2 1 The Australian e-health Research Centre, CSIRO ICT
More informationLipid annotation with MS2Analyzer. Yan Ma 10/24/2013
Lipid annotation with MS2Analyzer Yan Ma 10/24/2013 Checklist before you start You need to have: 1.A computer with Java environment and Office(2003 or higher) 2.MS/MS spectra in MGF files 3.Latest version
More information1. Q: What has changed from the draft recommendations posted for public comment in November/December 2011?
Frequently Asked Questions (FAQs) in regard to Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors 1. Q: What has changed from the draft recommendations
More information1.Basis of resistance 2.Mechanisms of resistance 3.How to overcome resistance. 13/10/2017 Sara Redaelli
Dott.ssa Sara Redaelli 13/10/2017 1.Basis of resistance 2.Mechanisms of resistance 3.How to overcome resistance Tumor Heterogeneity: Oncogenic Drivers in NSCLC The Promise of Genotype-Directed Therapy
More informationEvolution of Pathology
1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy
More informationRe: NCI Request for Information, Strategies for Matching Patients to Clinical Trials (NOT-CA )
American Cancer Society Cancer Action Network 555 11 th Street, NW Suite 300 Washington, DC 20004 202.661.5700 www.acscan.org Norman E. Sharpless, M.D. Director National Cancer Institute 9609 Medical Center
More informationEGFRIndb: Epidermal Growth Factor Receptor Inhibitor database
EGFRIndb: Epidermal Growth Factor Receptor Inhibitor database Inderjit S Yadav 1,3, Harinder Singh 2, Mohd. Imran Khan 1, Ashok Chaudhury 3, G.P.S. Raghava 2 and Subhash M. Agarwal 1 * 1 Bioinformatics
More informationA Method for Analyzing Commonalities in Clinical Trial Target Populations
A Method for Analyzing Commonalities in Clinical Trial Target Populations Zhe (Henry) He 1, Simona Carini 2, Tianyong Hao 1, Ida Sim 2, and Chunhua Weng 1 1 Department of Biomedical Informatics, Columbia
More informationLibreHealth EHR Student Exercises
LibreHealth EHR Student Exercises 1. Exercises with Test Patients created by students a. Create a new Encounter using the Bronchitis form (template) i. While your patient s chart is open, go to either
More informationSemi-Automatic Construction of Thyroid Cancer Intervention Corpus from Biomedical Abstracts
jsci2016 Semi-Automatic Construction of Thyroid Cancer Intervention Corpus from Biomedical Wutthipong Kongburan, Praisan Padungweang, Worarat Krathu, Jonathan H. Chan School of Information Technology King
More informationThe clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies
Patterson et al. Human Genomics (2016) 10:4 DOI 10.1186/s40246-016-0061-7 PRIMARY RESEARCH Open Access The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted
More informationUsing the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview
Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview Millions of people. Strong collaborations. Privacy first. Jeffrey Brown,
More informationChapter 12 Conclusions and Outlook
Chapter 12 Conclusions and Outlook In this book research in clinical text mining from the early days in 1970 up to now (2017) has been compiled. This book provided information on paper based patient record
More informationThe Expanding Value of Biomarkers in NSCLC Treatment
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/closing-gaps-nsclc/the-expanding-value-of-biomarkers-in-nsclctreatment/10283/
More informationDecember 13, The Future Reimbursement Environment for NGS for Oncology
WELCOME! Today s Speaker Mr. Mathews has worked on a variety of diagnostic reimbursement projects involving the analysis, development, and implementation of coding, coverage, and payment strategies for
More informationPhenotype analysis in humans using OMIM
Outline: 1) Introduction to OMIM 2) Phenotype similarity map 3) Exercises Phenotype analysis in humans using OMIM Rosario M. Piro Molecular Biotechnology Center University of Torino, Italy 1 MBC, Torino
More informationNational Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant
National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The NSABP Foundation
More informationAutomatic Context-Aware Image Captioning
Technical Disclosure Commons Defensive Publications Series May 23, 2017 Automatic Context-Aware Image Captioning Sandro Feuz Sebastian Millius Follow this and additional works at: http://www.tdcommons.org/dpubs_series
More informationGenome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl.
GenomeVIP: the Genome Institute at Washington University A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud R. Jay Mashl October 20, 2014 Turnkey Variant
More informationFacts from text: Automated gene annotation with ontologies and text-mining
1. Workshop des GI-Arbeitskreises Ontologien in Biomedizin und Lebenswissenschaften (OBML) Facts from text: Automated gene annotation with ontologies and text-mining Conrad Plake Schroeder Group (Bioinformatics),
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationIMPaLA tutorial.
IMPaLA tutorial http://impala.molgen.mpg.de/ 1. Introduction IMPaLA is a web tool, developed for integrated pathway analysis of metabolomics data alongside gene expression or protein abundance data. It
More informationSemantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS
Semantic Alignment between ICD-11 and SNOMED-CT By Marcie Wright RHIA, CHDA, CCS World Health Organization (WHO) owns and publishes the International Classification of Diseases (ICD) WHO was entrusted
More informationNext Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making
Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making November 20, 2014 Capturing Value in Next Generation Sequencing Symposium Douglas Johnson MD, MSCI Vanderbilt-Ingram
More informationDPV. Ramona Ranz, Andreas Hungele, Prof. Reinhard Holl
DPV Ramona Ranz, Andreas Hungele, Prof. Reinhard Holl Contents Possible use of DPV Languages Patient data Search for patients Patient s info Save data Mandatory fields Diabetes subtypes ICD 10 Fuzzy date
More informationClonal Evolution of saml. Johnnie J. Orozco Hematology Fellows Conference May 11, 2012
Clonal Evolution of saml Johnnie J. Orozco Hematology Fellows Conference May 11, 2012 CML: *bcr-abl and imatinib Melanoma: *braf and vemurafenib CRC: *k-ras and cetuximab Esophageal/Gastric: *Her-2/neu
More informationMET skipping mutation, EGFR
New NSCLC biomarkers in clinical research: detection of MET skipping mutation, EGFR T790M, and other important biomarkers Fernando López-Ríos Laboratorio de Dianas Terapéuticas Hospital Universitario HM
More informationLiquid biopsy: the experience of real life case studies
Liquid biopsy: the experience of real life case studies 10 th September 2018 Beatriz Bellosillo Servicio de Anatomía Patológica Hospital del Mar, Barcelona Agenda Introduction Experience in colorectal
More informationLung Cancer Concept Annotation from Spanish Clinical Narratives
Lung Cancer Concept Annotation from Spanish Clinical Narratives Marjan Najafabadipour 1, [0000-0002-1428-9330], Juan Manuel Tuñas 1[0000-0001-8241-5602], Alejandro Rodríguez-González 1,2,* [0000-0001-8801-4762]
More informationNGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation
NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation Michael R. Rossi, PhD, FACMG Assistant Professor Division of Cancer Biology, Department of Radiation Oncology Department
More informationDisclosures Genomic testing in lung cancer
Disclosures Genomic testing in lung cancer No disclosures Objectives Understand how FISH and NGS provide complementary data for the evaluation of lung cancer Recognize the challenges of performing testing
More information